KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+3.27%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$290M
AUM Growth
+$290M
Cap. Flow
-$6.6M
Cap. Flow %
-2.28%
Top 10 Hldgs %
99.68%
Holding
13
New
3
Increased
3
Reduced
7
Closed
–

Top Buys

1
KOD icon
Kodiak Sciences
KOD
$3.48M
2
BIIB icon
Biogen
BIIB
$1.75M
3
TARO
Taro Pharmaceutical Industries Ltd.
TARO
$1.17M
4
CAH icon
Cardinal Health
CAH
$748K
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
$411K

Top Sells

1
MCK icon
McKesson
MCK
$9.88M
2
REGN icon
Regeneron Pharmaceuticals
REGN
$1.54M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
$1.09M
4
EXEL icon
Exelixis
EXEL
$606K
5
UTHR icon
United Therapeutics
UTHR
$574K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$61.5B
$46.7M 16.1% 66,880 -2,200 -3% -$1.54M
ENTA icon
2
Enanta Pharmaceuticals
ENTA
$180M
$39.1M 13.46% 548,828 -15,274 -3% -$1.09M
MCK icon
3
McKesson
MCK
$85.4B
$38M 13.1% 124,165 -32,259 -21% -$9.88M
ALKS icon
4
Alkermes
ALKS
$4.78B
$37.5M 12.92% 1,424,204 -18,761 -1% -$494K
UTHR icon
5
United Therapeutics
UTHR
$13.8B
$36.2M 12.47% 201,612 -3,200 -2% -$574K
EXEL icon
6
Exelixis
EXEL
$10.1B
$34.7M 11.96% 1,530,406 -26,713 -2% -$606K
TARO
7
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$24.5M 8.44% 565,951 +26,984 +5% +$1.17M
BIIB icon
8
Biogen
BIIB
$19.4B
$23.5M 8.08% 111,353 +8,300 +8% +$1.75M
EGRX
9
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5.68M 1.96% 114,787 +8,300 +8% +$411K
KOD icon
10
Kodiak Sciences
KOD
$478M
$3.48M 1.2% +450,600 New +$3.48M
CAH icon
11
Cardinal Health
CAH
$35.5B
$748K 0.26% +13,200 New +$748K
NXTC icon
12
NextCure
NXTC
$13.5M
$149K 0.05% 30,591 -436 -1% -$2.12K
ASMB icon
13
Assembly Biosciences
ASMB
$190M
$21K 0.01% +10,100 New +$21K